Mwengee William, Butler Thomas, Mgema Samuel, Mhina George, Almasi Yusuf, Bradley Charles, Formanik James B, Rochester C George
Regional Medical Office, Tanga, Tanzania.
Clin Infect Dis. 2006 Mar 1;42(5):614-21. doi: 10.1086/500137. Epub 2006 Jan 25.
Over the past 50 years, antibiotics of choice for treatment of plague, including streptomycin, chloramphenicol, and tetracycline, have mostly become outdated or unavailable. To test gentamicin in the treatment of naturally occurring plague and the implications of its use in the treatment of bioterrorist plague, a randomized, comparative, open-label, clinical trial comparing monotherapy with gentamicin or doxycycline was conducted in Tanzania.
Sixty-five adults and children with symptoms of bubonic, septicemic, or pneumonic plague of < or =3 days duration were enrolled in the study. Bubo aspirates and blood were cultured for Yersinia pestis. Acute-phase and convalescent-phase serum samples were tested for antibody against fraction 1 antigen of Y. pestis. Thirty-five patients were randomized to receive gentamicin (2.5 mg/kg intramuscularly every 12 h for 7 days), and 30 patients were randomized to receive doxycycline (100 mg [adults] and 2.2 mg/kg [children] orally every 12 h for 7 days). Serum creatinine concentrations were measured before and after treatment, and peak and trough concentrations of antibiotics were measured.
Three patients, 2 of whom were treated with gentamicin and 1 of whom was treated with doxycycline, died on the first or second day of treatment, and these deaths were attributed to advanced disease and complications including pneumonia, septicemia, hemorrhage, and renal failure at the start of therapy. All other patients experienced cure or an improved condition after receiving therapy, resulting in favorable response rates of 94% for gentamicin (95% CI, 81.1%-99.0%) and 97% for doxycycline (95% CI, 83.4%-99.8%). Y. pestis isolates obtained from 30 patients belonged to biotype antigua and were susceptible to gentamicin and doxycycline, which had MICs of 0.13 mg/L and 0.25-0.5 mg/L, respectively. Serum concentrations of antibiotics were within therapeutic ranges, and adverse events were infrequent. Patients treated with gentamicin demonstrated a modest increase in the mean serum creatinine concentration after treatment (P<.05, by paired t test).
Both gentamicin and doxycycline were effective therapies for adult and pediatric plague, with high rates of favorable responses and low rates of adverse events.
在过去50年中,用于治疗鼠疫的首选抗生素,包括链霉素、氯霉素和四环素,大多已过时或无法获取。为了测试庆大霉素治疗自然发生的鼠疫的效果及其在治疗生物恐怖主义鼠疫中的应用意义,在坦桑尼亚进行了一项随机、对照、开放标签的临床试验,比较庆大霉素或多西环素单药治疗。
65名患有持续时间≤3天的腺鼠疫、败血症型鼠疫或肺鼠疫症状的成人和儿童纳入研究。对腹股沟淋巴结抽吸物和血液进行鼠疫耶尔森菌培养。检测急性期和恢复期血清样本中针对鼠疫耶尔森菌1号抗原的抗体。35名患者随机接受庆大霉素治疗(每12小时肌内注射2.5mg/kg,共7天),30名患者随机接受多西环素治疗(成人100mg,儿童2.2mg/kg,每12小时口服1次,共7天)。在治疗前后测量血清肌酐浓度,并测量抗生素的峰浓度和谷浓度。
3名患者在治疗的第1天或第2天死亡,其中2名接受庆大霉素治疗,1名接受多西环素治疗,这些死亡归因于疾病进展以及包括治疗开始时的肺炎、败血症、出血和肾衰竭等并发症。所有其他患者在接受治疗后治愈或病情改善,庆大霉素的良好反应率为94%(95%CI,81.1%-99.0%),多西环素为97%(95%CI,83.4%-99.8%)。从30名患者中分离出的鼠疫耶尔森菌菌株属于安提瓜生物型,对庆大霉素和多西环素敏感,其MIC分别为0.13mg/L和0.25 - 0.5mg/L。抗生素血清浓度在治疗范围内,不良事件很少。接受庆大霉素治疗的患者在治疗后平均血清肌酐浓度有适度升高(配对t检验,P<0.05)。
庆大霉素和多西环素都是治疗成人和儿童鼠疫的有效疗法,具有高良好反应率和低不良事件发生率。